IL143143A0 - USE OF A 5HT2A AND 5HT2A/C RECEPTOR ANTAGONIST FOR PREPARING MEDICINES FOR TREATING SNORING AND HIGH RESISTAnCE SYNDROME OF UPPER ANATOMICAL AIRWAYS - Google Patents
USE OF A 5HT2A AND 5HT2A/C RECEPTOR ANTAGONIST FOR PREPARING MEDICINES FOR TREATING SNORING AND HIGH RESISTAnCE SYNDROME OF UPPER ANATOMICAL AIRWAYSInfo
- Publication number
- IL143143A0 IL143143A0 IL14314399A IL14314399A IL143143A0 IL 143143 A0 IL143143 A0 IL 143143A0 IL 14314399 A IL14314399 A IL 14314399A IL 14314399 A IL14314399 A IL 14314399A IL 143143 A0 IL143143 A0 IL 143143A0
- Authority
- IL
- Israel
- Prior art keywords
- 5ht2a
- high resistance
- receptor antagonist
- resistance syndrome
- preparing medicines
- Prior art date
Links
- 206010041235 Snoring Diseases 0.000 title abstract 2
- 239000002464 receptor antagonist Substances 0.000 title abstract 2
- 229940044551 receptor antagonist Drugs 0.000 title abstract 2
- 208000011580 syndromic disease Diseases 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9816295A FR2787328A1 (fr) | 1998-12-22 | 1998-12-22 | Utilisation d'un antagoniste des recepteurs 5ht2a pour la preparation de medicaments utiles dans le traitement des ronflements et du syndrome de haute resistance ou de resistance des voies aeriennes superieures |
| PCT/FR1999/003122 WO2000037068A1 (fr) | 1998-12-22 | 1999-12-14 | Utilisation d'un antagoniste des recepteurs 5ht2a, et 5ht2a/c pour la preparation de medicaments destines au traitement des ronflements et du syndrome de haute resistance des voies aeriennes superieures |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL143143A0 true IL143143A0 (en) | 2002-04-21 |
Family
ID=9534374
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14314399A IL143143A0 (en) | 1998-12-22 | 1999-12-14 | USE OF A 5HT2A AND 5HT2A/C RECEPTOR ANTAGONIST FOR PREPARING MEDICINES FOR TREATING SNORING AND HIGH RESISTAnCE SYNDROME OF UPPER ANATOMICAL AIRWAYS |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6576670B1 (ja) |
| EP (1) | EP1140055B1 (ja) |
| JP (1) | JP2002532548A (ja) |
| KR (1) | KR20010086459A (ja) |
| CN (1) | CN1331588A (ja) |
| AT (1) | ATE236625T1 (ja) |
| AU (1) | AU1570200A (ja) |
| BR (1) | BR9916434A (ja) |
| CA (1) | CA2351674A1 (ja) |
| DE (1) | DE69906795D1 (ja) |
| FR (1) | FR2787328A1 (ja) |
| IL (1) | IL143143A0 (ja) |
| NO (1) | NO20013118L (ja) |
| WO (1) | WO2000037068A1 (ja) |
| ZA (1) | ZA200104399B (ja) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060069124A1 (en) * | 2004-09-07 | 2006-03-30 | Rao P S | Use of MDL-100,907 for treatment of allergic and eosinophil mediated diseases |
| EP2255807A1 (en) | 2009-05-26 | 2010-12-01 | Sanofi-Aventis | Method of treating sleep disorders using the combination of eplivanserin and zolpidem |
| EP2269600A1 (en) * | 2009-07-02 | 2011-01-05 | Sanofi-Aventis | Treatment of sleep disorders using eplivanserin in COPD patients |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2639942B1 (fr) * | 1988-12-02 | 1991-03-29 | Sanofi Sa | Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant |
| WO1991018602A1 (en) | 1990-06-01 | 1991-12-12 | Merrell Dow Pharmaceuticals Inc. | (+)-α-(2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL |
| DE19707628A1 (de) | 1997-02-26 | 1998-08-27 | Merck Patent Gmbh | Oxazolidinone |
| US5844000A (en) * | 1997-06-12 | 1998-12-01 | Sanofi | Propenone oxime ethers and pharmaceutical compositions containing them |
| FR2765107B1 (fr) | 1997-06-26 | 2000-03-24 | Sanofi Sa | Utilisation d'un antagoniste specifique des recepteurs 5ht2 pour la preparation de medicaments utiles dans le traitement du syndrome d'apnee du sommeil |
| EP1066036B1 (en) * | 1998-02-27 | 2006-04-26 | The Board Of Trustees Of The University Of Illinois | Agents with serotonin-related activity for the treatment for sleep apnea |
| US6277864B1 (en) * | 1998-08-28 | 2001-08-21 | Aventis Pharmaceuticals Inc. | Use of R- +)-α-(2,3-dimethoxyphenyl-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol for the treatment of sleep disorders |
-
1998
- 1998-12-22 FR FR9816295A patent/FR2787328A1/fr active Pending
-
1999
- 1999-12-14 WO PCT/FR1999/003122 patent/WO2000037068A1/fr not_active Application Discontinuation
- 1999-12-14 BR BR9916434-5A patent/BR9916434A/pt not_active Application Discontinuation
- 1999-12-14 KR KR1020017007849A patent/KR20010086459A/ko not_active Application Discontinuation
- 1999-12-14 EP EP99958316A patent/EP1140055B1/fr not_active Expired - Lifetime
- 1999-12-14 US US09/868,532 patent/US6576670B1/en not_active Expired - Lifetime
- 1999-12-14 JP JP2000589179A patent/JP2002532548A/ja not_active Withdrawn
- 1999-12-14 CN CN99814969A patent/CN1331588A/zh active Pending
- 1999-12-14 IL IL14314399A patent/IL143143A0/xx unknown
- 1999-12-14 AT AT99958316T patent/ATE236625T1/de not_active IP Right Cessation
- 1999-12-14 DE DE69906795T patent/DE69906795D1/de not_active Expired - Lifetime
- 1999-12-14 AU AU15702/00A patent/AU1570200A/en not_active Abandoned
- 1999-12-14 CA CA002351674A patent/CA2351674A1/en not_active Abandoned
-
2001
- 2001-05-29 ZA ZA200104399A patent/ZA200104399B/en unknown
- 2001-06-21 NO NO20013118A patent/NO20013118L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2351674A1 (en) | 2000-06-29 |
| CN1331588A (zh) | 2002-01-16 |
| BR9916434A (pt) | 2001-09-04 |
| WO2000037068B1 (fr) | 2000-09-14 |
| NO20013118D0 (no) | 2001-06-21 |
| NO20013118L (no) | 2001-07-23 |
| KR20010086459A (ko) | 2001-09-12 |
| ZA200104399B (en) | 2002-05-02 |
| EP1140055B1 (fr) | 2003-04-09 |
| DE69906795D1 (de) | 2003-05-15 |
| US6576670B1 (en) | 2003-06-10 |
| WO2000037068A1 (fr) | 2000-06-29 |
| FR2787328A1 (fr) | 2000-06-23 |
| EP1140055A1 (fr) | 2001-10-10 |
| AU1570200A (en) | 2000-07-12 |
| JP2002532548A (ja) | 2002-10-02 |
| ATE236625T1 (de) | 2003-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO1995031985A3 (en) | Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies | |
| YU71901A (sh) | NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA | |
| AP2000001785A0 (en) | Medicaments | |
| HUP0302044A3 (en) | Association of the cb1 receptor antagonist and a sibutramin, pharmaceutical compositions containing same and use thereof for treating obesity | |
| PL398391A1 (pl) | Koniugat hydroksyalkiloskrobi i polipeptydu, sposób wytwarzania tego koniugatu, jego zastosowanie oraz kompozycja farmaceutyczna zawierająca koniugat hydroksyalkiloskrobi i polipeptydu | |
| CA2295119A1 (en) | Use of a specific antagonist of 5ht2 receptors for preparing medicines useful for treating sleep-disordered breathing | |
| BR0311898A (pt) | Tratamento de associação para depressão e ansiedade com antagonistas de nk1 e nk3 | |
| MXPA01008993A (es) | Tratamiento de combinacion para depresion y ansiedad. | |
| IL198759A (en) | Use of 3gal receptor antagonists to prepare medications to treat depression and / or anxiety | |
| IL145269A0 (en) | Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders or mixed anxiety-depression disorders | |
| IL143143A0 (en) | USE OF A 5HT2A AND 5HT2A/C RECEPTOR ANTAGONIST FOR PREPARING MEDICINES FOR TREATING SNORING AND HIGH RESISTAnCE SYNDROME OF UPPER ANATOMICAL AIRWAYS | |
| ATE330599T1 (de) | Verwendung von angiotensin ii rezeptorantagonisten zur behandlung von akutem myokardischen infarkt | |
| WO2000025766A3 (en) | Use of nk antagonist for treating gastric asthma | |
| AU2001225664A1 (en) | 5-ht3 receptor antagonists for treatment of disorders involving airway constriction | |
| WO2002069944A3 (de) | Neue arzneimittelkompositionen auf der basis von anticholinergika und nk1-rezeptor-antagonisten | |
| HUP0201709A3 (en) | Ureidopiperidine derivatives as selective human nk3 receptor antagonists, pharmaceutical compositions containing them and use of them for producing pharmaceutical compositions | |
| NO996060D0 (no) | Pusteapparat for behandling av soevnapne | |
| MXPA01006319A (es) | Uso de los antagonistas del receptor para 5ht, para el tratamiento de sindrome de fatiga cronica. | |
| AU6991300A (en) | Use of 5-ht3 receptor antagonists for the treatment of inflammations of the respiratory tract | |
| ZA9810469B (en) | Use of a specific 5ht2 receptor antagonist for the preparation of medicines useful in the treatment of the sleep apnea syndrome | |
| WO2004019991A3 (en) | Scatter factor/hepatocyte growth factor antagonist nk4 for the treatment of glioma | |
| PL374077A1 (en) | Use of 5-ht2 receptor antagonists for the treatment of sleep disorders |